No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
WatchlistPaper Trade
BigAlMoney : Sangamo's Fabry results are much better. We have Accelerated Approval Pathway from FDA recently. Gets a drug to market 3 years sooner. No expensive Phase 3 required. Existing cohorts just monitored by eGFR, 5 dollar lab test. BLA can be filed thus year. In discussions with several big Pharma for buyout or Partnership.